Thanks for the reference to the correlation between HRCT and FVC.
I was thinking more if they decide to either go head to head or in combination with Esbriet and/or Ofev. A comparison with HRCT may be more favorable then relying on FVC alone where both drugs have shown benefit. I don't know much about nintedanib but I don't believe pirfenidone has ever been shown to have improved fibrosis (aside from anecdotal cases).
Market Data 
Markets 
AI
